z-logo
open-access-imgOpen Access
Reactivation Versus Clearance of Mycobacterium tuberculosis Using Mammalian Target of Rapamycin Inhibitors in Patients With Cancer Can Be Context Dependent
Author(s) -
Salvador Vale
Publication year - 2013
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2013.49.1225
Subject(s) - temsirolimus , pi3k/akt/mtor pathway , sirolimus , latent tuberculosis , medicine , context (archaeology) , mycobacterium tuberculosis , cancer research , immunology , lung cancer , cancer , immunity , immune system , tuberculosis , biology , oncology , discovery and development of mtor inhibitors , pathology , apoptosis , paleontology , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom